DE3751331D1 - Nachweisverfahren eines zellenoberflächenantigens. - Google Patents

Nachweisverfahren eines zellenoberflächenantigens.

Info

Publication number
DE3751331D1
DE3751331D1 DE3751331T DE3751331T DE3751331D1 DE 3751331 D1 DE3751331 D1 DE 3751331D1 DE 3751331 T DE3751331 T DE 3751331T DE 3751331 T DE3751331 T DE 3751331T DE 3751331 D1 DE3751331 D1 DE 3751331D1
Authority
DE
Germany
Prior art keywords
cell surface
detecting
present
provides
antique
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE3751331T
Other languages
English (en)
Other versions
DE3751331T2 (de
Inventor
Robert Mcmillan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Scripps Research Institute
Original Assignee
Scripps Clinic and Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/936,125 external-priority patent/US4810632A/en
Application filed by Scripps Clinic and Research Foundation filed Critical Scripps Clinic and Research Foundation
Application granted granted Critical
Publication of DE3751331D1 publication Critical patent/DE3751331D1/de
Publication of DE3751331T2 publication Critical patent/DE3751331T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G02—OPTICS
    • G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/29—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the position or the direction of light beams, i.e. deflection
    • G02F1/31—Digital deflection, i.e. optical switching
    • G02F1/313—Digital deflection, i.e. optical switching in an optical waveguide structure
    • G02F1/3131—Digital deflection, i.e. optical switching in an optical waveguide structure in optical fibres
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • G—PHYSICS
    • G02—OPTICS
    • G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00—Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/35—Non-linear optics
    • G02F1/3515—All-optical modulation, gating, switching, e.g. control of a light beam by another light beam
    • G02F1/3517—All-optical modulation, gating, switching, e.g. control of a light beam by another light beam using an interferometer
    • G02F1/3519—All-optical modulation, gating, switching, e.g. control of a light beam by another light beam using an interferometer of Sagnac type, i.e. nonlinear optical loop mirror [NOLM]
    • G—PHYSICS
    • G02—OPTICS
    • G02F—OPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F3/00—Optical logic elements; Optical bistable devices

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Nonlinear Science (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Optics & Photonics (AREA)
  • Rheumatology (AREA)
  • Power Engineering (AREA)
  • Rehabilitation Therapy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
DE3751331T 1986-12-01 1987-11-25 Nachweisverfahren eines zellenoberflächenantigens. Expired - Lifetime DE3751331T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US06/936,125 US4810632A (en) 1986-12-01 1986-12-01 Cell surface antigen detection method
US07/124,905 US5176998A (en) 1986-12-01 1987-11-24 Cell surface antigen detection method
PCT/US1987/003129 WO1988004432A1 (en) 1986-12-01 1987-11-25 Cell surface antigen detection method

Publications (2)

Publication Number Publication Date
DE3751331D1 true DE3751331D1 (de) 1995-07-06
DE3751331T2 DE3751331T2 (de) 1996-02-01

Family

ID=26823073

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3751331T Expired - Lifetime DE3751331T2 (de) 1986-12-01 1987-11-25 Nachweisverfahren eines zellenoberflächenantigens.

Country Status (9)

Country Link
US (2) US5176998A (de)
EP (1) EP0290595B1 (de)
JP (1) JP2803824B2 (de)
AT (1) ATE123341T1 (de)
AU (1) AU594554B2 (de)
DE (1) DE3751331T2 (de)
DK (1) DK173838B1 (de)
FI (1) FI95082C (de)
NO (1) NO172910C (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5176998A (en) * 1986-12-01 1993-01-05 The Scripps Research Institute Cell surface antigen detection method
US5525461A (en) * 1991-11-01 1996-06-11 T Cell Diagnostics, Inc. Therapeutic and diagnostic methods using total leukocyte surface antigens
US5731425A (en) * 1994-10-28 1998-03-24 Eastman Kodak Company Polypeptide surface marker for cells
US6984526B2 (en) 1995-02-08 2006-01-10 University Of South Florida Spectrophotometric method for determining the viability of a sample containing platelets
US6330058B1 (en) 1999-04-14 2001-12-11 University Of South Florida Spectrophotometric method and apparatus for blood typing
US6379903B1 (en) 1999-10-08 2002-04-30 Sigma-Aldrich Co. Purification of recombinant proteins fused to multiple epitopes
CN102203610A (zh) 2008-12-01 2011-09-28 利兰·斯坦福青年大学托管委员会 用于检测补体结合性抗体的方法和组合物
WO2012070964A1 (ru) * 2010-11-22 2012-05-31 Farber Boris Slavinovich Модифицированные олигопептиды с противораковыми свойствами и способ их получения
CN105308457B (zh) 2013-03-14 2018-07-10 斯坦福大学托管董事会 检测供体特异性抗体的方法和用于实施所述方法的系统
US10527613B2 (en) 2015-11-10 2020-01-07 The Board Of Trustees Of The Leland Stanford Junior University Biomarker detection methods and systems and kits for practicing same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4342566A (en) * 1980-02-22 1982-08-03 Scripps Clinic & Research Foundation Solid phase anti-C3 assay for detection of immune complexes
US4443427A (en) * 1982-06-21 1984-04-17 Sidney Farber Cancer Institute, Inc. Monoclonal antibody
US4643971A (en) * 1983-03-11 1987-02-17 Sloan-Kettering Institute Monoclonal antibodies to human bladder and ureter cancers and method
EP0149168B1 (de) * 1983-12-19 1991-04-24 Daiichi Pure Chemicals Co. Ltd. Immuntest
US4695538A (en) * 1984-06-01 1987-09-22 Sloan-Kettering Institute For Cancer Research Human monoclonal antibodies to cell surface antigens
EP0169729A3 (de) * 1984-07-23 1988-08-03 Becton Dickinson and Company Gewinnung von Zellenrezeptoren
US4670394A (en) * 1984-11-16 1987-06-02 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Isolation and culture of adrenal medullary endothelial cells producing blood clotting factor VIII:C
US4810632A (en) * 1986-12-01 1989-03-07 Scripps Clinic And Research Foundation Cell surface antigen detection method
US5176998A (en) * 1986-12-01 1993-01-05 The Scripps Research Institute Cell surface antigen detection method

Also Published As

Publication number Publication date
DE3751331T2 (de) 1996-02-01
FI95082C (fi) 1995-12-11
DK426588A (da) 1988-07-29
FI883585A0 (fi) 1988-07-29
US5336597A (en) 1994-08-09
ATE123341T1 (de) 1995-06-15
NO172910B (no) 1993-06-14
JPH01501571A (ja) 1989-06-01
NO172910C (no) 1993-09-22
FI883585A (fi) 1988-07-29
AU1087688A (en) 1988-06-30
NO883367L (no) 1988-07-29
EP0290595A1 (de) 1988-11-17
FI95082B (fi) 1995-08-31
NO883367D0 (no) 1988-07-29
DK426588D0 (da) 1988-07-29
AU594554B2 (en) 1990-03-08
EP0290595A4 (en) 1990-12-19
EP0290595B1 (de) 1995-05-31
DK173838B1 (da) 2001-12-10
US5176998A (en) 1993-01-05
JP2803824B2 (ja) 1998-09-24

Similar Documents

Publication Publication Date Title
GB1436934A (en) Method of testing blood
HK1044819A1 (en) Method for separating cells using immunorosettes.
DK190682A (da) Fremgangsmaade til analyse af antistoffer samt reagens dertil
ES2098744T3 (es) Ensayo inmunologico en fase solida.
DE3751331D1 (de) Nachweisverfahren eines zellenoberflächenantigens.
NO932320D0 (no) Fremgangsmaate for paavisning av en analytt i en proeve og et utstyrsett for denne
EP0396115A3 (de) Verfahren zur Bildung von Agglutinaten in Blutproben
DK196282A (da) Fremgangsmaade samt kit til bestemmelse af antistoffer mod oploeselige antigener
NO177444C (no) Fremgangsmåte for immunometrisk bestemmelse av et antigen, samt utstyrspakke for slik bestemmelse
DE3270252D1 (en) Radioimmunoassay for fibrinopeptide a
IT8023609A0 (it) Composizioni atte a separare le emazie dal siero o plasma in campioni di sangue per analisi emetodo che le utilizza.
EP0311094A3 (de) Diagnostisches Mittel und Verfahren zur Bestimmung von Apolipoprotein B
DE3674933D1 (de) Spezifisch hemmender speichel-alpha-amylase monoklonaler antikoerper und dessen verwendung zur bestimmung von pankreas-alpha-amylase.
DE3482924D1 (de) Reagenz zur verwendung im nachweis des antikoerpers gegen menschliche t-zellen-leukemievirusantigene.
KR850008620A (ko) Atl 바이러스 항체의 측정방법 및 시약
ES8705232A1 (es) Un metodo para preparar un anticuerpo monoclonal destinado autilizarse como auxiliar de diagnostico para detectar cancerde pulmon
DE3477610D1 (en) Method for the immunochemical determination of hepatitis b core antigens
EP0328372A3 (de) Verfahren zur Bestimmung von Antigenen
ATE64466T1 (de) Immuntest.
DK305084D0 (da) Partikel samt fremgangsmaade til paavisning af antigener og/eller antistoffer under anvendelse af partiklen
EP0389929A3 (de) Verfahren zur Bestimmung von Zelloberflächen-Antigen durch ein komplexes Antigen-Antikörper-Reaktionssystem und in diesem Verfahren verwendeter Apparat zur Fixierung von Immunozyten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition